Churg-Strauss syndrome causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
==Causes== | ==Causes== | ||
===Life-threatening Causes=== | ===Life-threatening Causes=== | ||
*Life-threatening [[Etiology|causes]] include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of [[Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis,]] however complications resulting from untreated [[eosinophilic granulomatosis with polyangiitis]] | *Life-threatening [[Etiology|causes]] include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of [[Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis,]] however complications resulting from untreated [[eosinophilic granulomatosis with polyangiitis]] are common. | ||
===Causes=== | ===Causes=== | ||
*The causes for eosinophilic granulomatosis with | *The causes for [[eosinophilic granulomatosis with polyangiitis]] are not known.<ref name="pmid14740430">{{cite journal |vauthors=Hellmich B, Ehlers S, Csernok E, Gross WL |title=Update on the pathogenesis of Churg-Strauss syndrome |journal=Clin. Exp. Rheumatol. |volume=21 |issue=6 Suppl 32 |pages=S69–77 |date=2003 |pmid=14740430 |doi= |url=}}</ref><ref name="pmid29240526">{{cite journal |vauthors=Safran T, Masckauchan M, Maj J, Green L |title=Wells syndrome secondary to influenza vaccination: A case report and review of the literature |journal=Hum Vaccin Immunother |volume= |issue= |pages=1–3 |date=December 2017 |pmid=29240526 |doi=10.1080/21645515.2017.1417714 |url=}}</ref> | ||
*Environmental agents and drugs may be responsibe for development of eosinophilic granulomatosis with polyangiitis through an allergic or autoimmune | *[[Environmental factor|Environmental agents]] and [[:Category:Drugs|drugs]] may be responsibe for development of eosinophilic granulomatosis with polyangiitis through an [[Allergy|allergic]] or [[Autoimmunity|autoimmune response]]. | ||
**Allergens | **[[Allergen|Allergens]] | ||
**Infections | **[[Infection|Infections]] | ||
**Vaccinations | **[[Vaccination|Vaccinations]] (eg, [[influenza]]) | ||
**Drugs:<ref name="pmid18549941">{{cite journal |vauthors=Puéchal X, Rivereau P, Vinchon F |title=Churg-Strauss syndrome associated with omalizumab |journal=Eur. J. Intern. Med. |volume=19 |issue=5 |pages=364–6 |date=July 2008 |pmid=18549941 |doi=10.1016/j.ejim.2007.09.001 |url=}}</ref><ref name="pmid23820041">{{cite journal |vauthors=Gómez-Puerta JA, Gedmintas L, Costenbader KH |title=The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis |journal=Autoimmun Rev |volume=12 |issue=12 |pages=1129–35 |date=October 2013 |pmid=23820041 |pmc=4086751 |doi=10.1016/j.autrev.2013.06.016 |url=}}</ref><ref name="pmid8834352">{{cite journal |vauthors=Orriols R, Muñoz X, Ferrer J, Huget P, Morell F |title=Cocaine-induced Churg-Strauss vasculitis |journal=Eur. Respir. J. |volume=9 |issue=1 |pages=175–7 |date=January 1996 |pmid=8834352 |doi= |url=}}</ref> | **Drugs:<ref name="pmid18549941">{{cite journal |vauthors=Puéchal X, Rivereau P, Vinchon F |title=Churg-Strauss syndrome associated with omalizumab |journal=Eur. J. Intern. Med. |volume=19 |issue=5 |pages=364–6 |date=July 2008 |pmid=18549941 |doi=10.1016/j.ejim.2007.09.001 |url=}}</ref><ref name="pmid23820041">{{cite journal |vauthors=Gómez-Puerta JA, Gedmintas L, Costenbader KH |title=The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis |journal=Autoimmun Rev |volume=12 |issue=12 |pages=1129–35 |date=October 2013 |pmid=23820041 |pmc=4086751 |doi=10.1016/j.autrev.2013.06.016 |url=}}</ref><ref name="pmid8834352">{{cite journal |vauthors=Orriols R, Muñoz X, Ferrer J, Huget P, Morell F |title=Cocaine-induced Churg-Strauss vasculitis |journal=Eur. Respir. J. |volume=9 |issue=1 |pages=175–7 |date=January 1996 |pmid=8834352 |doi= |url=}}</ref> | ||
***Leukotriene receptor antagonists (eg, montelukast, zafirlukast) | ***[[Leukotriene antagonist|Leukotriene receptor antagonists]] (eg, [[montelukast]], [[zafirlukast]]) | ||
***Anti IgE antibodies (eg, omalizumab) | ***Anti IgE antibodies (eg, [[omalizumab]]) | ||
***Mesalazine | ***[[Mesalazine]] | ||
***Propylthiouracil | ***[[Propylthiouracil]] | ||
***Methimazole | ***[[Methimazole]] | ||
***Exposure to silica | ***[[Silica|Exposure to silica]] | ||
***Cocaine | ***[[Cocaine]] | ||
===Genetic Causes=== | ===Genetic Causes=== | ||
Revision as of 17:12, 30 March 2018
|
Churg-Strauss syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Churg-Strauss syndrome causes On the Web |
|
American Roentgen Ray Society Images of Churg-Strauss syndrome causes |
|
Risk calculators and risk factors for Churg-Strauss syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
Disease name] may be caused by [cause1], [cause2], or [cause3].
OR
Common causes of [disease] include [cause1], [cause2], and [cause3].
OR
The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
OR
The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.
Causes
Life-threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of eosinophilic granulomatosis with polyangiitis, however complications resulting from untreated eosinophilic granulomatosis with polyangiitis are common.
Causes
- The causes for eosinophilic granulomatosis with polyangiitis are not known.[1][2]
- Environmental agents and drugs may be responsibe for development of eosinophilic granulomatosis with polyangiitis through an allergic or autoimmune response.
- Allergens
- Infections
- Vaccinations (eg, influenza)
- Drugs:[3][4][5]
- Leukotriene receptor antagonists (eg, montelukast, zafirlukast)
- Anti IgE antibodies (eg, omalizumab)
- Mesalazine
- Propylthiouracil
- Methimazole
- Exposure to silica
- Cocaine
Genetic Causes
- [Disease name] is caused by a mutation in the [gene name] gene.
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the disease in alphabetical order.
The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3References
- ↑ Hellmich B, Ehlers S, Csernok E, Gross WL (2003). "Update on the pathogenesis of Churg-Strauss syndrome". Clin. Exp. Rheumatol. 21 (6 Suppl 32): S69–77. PMID 14740430.
- ↑ Safran T, Masckauchan M, Maj J, Green L (December 2017). "Wells syndrome secondary to influenza vaccination: A case report and review of the literature". Hum Vaccin Immunother: 1–3. doi:10.1080/21645515.2017.1417714. PMID 29240526.
- ↑ Puéchal X, Rivereau P, Vinchon F (July 2008). "Churg-Strauss syndrome associated with omalizumab". Eur. J. Intern. Med. 19 (5): 364–6. doi:10.1016/j.ejim.2007.09.001. PMID 18549941.
- ↑ Gómez-Puerta JA, Gedmintas L, Costenbader KH (October 2013). "The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis". Autoimmun Rev. 12 (12): 1129–35. doi:10.1016/j.autrev.2013.06.016. PMC 4086751. PMID 23820041.
- ↑ Orriols R, Muñoz X, Ferrer J, Huget P, Morell F (January 1996). "Cocaine-induced Churg-Strauss vasculitis". Eur. Respir. J. 9 (1): 175–7. PMID 8834352.